Cargando…

Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1–2 lesions

BACKGROUND: Human Papilloma Virus (HPV) DNA tests are highly sensitive and can triage women with mild lesions, improving the prognosis and diagnosis of cervical lesions. However, additional efficient strategies should be developed to improve the specificity of these tests. METHODS: This study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yuejie, Liu, Jie, Gong, Li, Sun, Xingwang, Long, Wenbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794830/ https://www.ncbi.nlm.nih.gov/pubmed/31619262 http://dx.doi.org/10.1186/s12985-019-1225-6

Ejemplares similares

Ki-67 and P16 proteins in cervical cancer and precancerous lesions of young women and the diagnostic value for cervical cancer and precancerous lesions
por: Shi, Qin, et al.
Publicado: (2019)

Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM
por: Serrano-Villar, Sergio, et al.
Publicado: (2017)

Frequency of Chlamydia trachomatis infection in cervical intraepithelial lesions and the status of cytological p16/Ki-67 dual-staining
por: Robial, R., et al.
Publicado: (2017)

Application of p16/Ki-67 dual-staining cytology in cervical cancers
por: Yu, Li, et al.
Publicado: (2019)

Three-tiered score for Ki-67 and p16(ink4a) improves accuracy and reproducibility of grading CIN lesions
por: van Zummeren, Marjolein, et al.
Publicado: (2018)

The Role of p16/Ki67 Dual Staining in Cervical Cancer Screening
por: Dovnik, Andraž, et al.
Publicado: (2023)

Risk of progression of early cervical lesions is associated with integration and persistence of HPV-16 and expression of E6, Ki-67, and telomerase
por: Vega-Peña, Arianna, et al.
Publicado: (2013)

Associations between the expression of SCCA, MTA1, P16, Ki-67 and the infection of high-risk HPV in cervical lesions
por: Han, Cuina, et al.
Publicado: (2020)

Analysis of HPV distribution in patients with cervical precancerous lesions in Western China
por: Li, Kemin, et al.
Publicado: (2017)

The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL
por: Possati-Resende, Júlio C., et al.
Publicado: (2015)

Clinical significance of HPV-DNA testing for precancerous cervical lesionS
por: Moarcăs, M, et al.
Publicado: (2014)

HPV genotyping and p16/Ki-67 test significantly improve detection rate of high-grade cervical squamous intraepithelial lesion
por: Lewitowicz, Piotr, et al.
Publicado: (2019)

HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix
por: Long, Wenbo, et al.
Publicado: (2018)

Immunodetectable cyclin D (1) is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions
por: Shoker, B S, et al.
Publicado: (2001)

P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women
por: Aromseree, Sirinart, et al.
Publicado: (2022)

Evaluation of p16/Ki-67 Dual Staining Compared with HPV Genotyping in Anal Cytology with Diagnosis of ASC-US for Detection of High-Grade Anal Intraepithelial Lesions
por: Pichon, Maxime, et al.
Publicado: (2019)

p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening
por: Han, Qin, et al.
Publicado: (2020)

Comparison of Ki67 index and P16 expression in different grades of cervical squamous intraepithelial lesions
por: Hosseini, Maryam Sadat, et al.
Publicado: (2023)

Triage Strategies for Non-16/Non-18 HPV-Positive Women in Primary HPV-Based Cervical Cancer Screening: p16/Ki67 Dual Stain vs. Cytology
por: Mazurec, Karolina, et al.
Publicado: (2023)

Analysis of ROC: The value of HPV16 E6 protein in the diagnosis of early stage cervical carcinoma and precancerous lesions
por: Sun, Li, et al.
Publicado: (2016)

Interobserver variability and accuracy of p16/Ki-67 dual immunocytochemical staining on conventional cervical smears
por: Kloboves Prevodnik, Veronika, et al.
Publicado: (2019)

Conservative management of CIN2 p16 positive lesions in women with multiple HPV infection
por: Bruno, Maria Teresa, et al.
Publicado: (2020)

Evaluation of Ki67, p16 and CK17 Markers in Differentiating Cervical Intraepithelial Neoplasia and Benign Lesions
por: Sari Aslani, Fatemeh, et al.
Publicado: (2013)

The Utility of p16INK4a and Ki-67 as a Conjunctive Tool in Uterine Cervical Lesions
por: Lee, Sangho, et al.
Publicado: (2012)

Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening
por: Harper, Diane M., et al.
Publicado: (2023)

Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients
por: Kim, Tae Jin, et al.
Publicado: (2014)

Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study
por: Ikenberg, Hans, et al.
Publicado: (2013)

Significance of Triple Detection of p16/ki-67 Dual-Staining, Liquid-Based Cytology and HR HPV Testing in Screening of Cervical Cancer: A Retrospective Study
por: Yu, Li, et al.
Publicado: (2022)

The p16/ki-67 assay is a safe, effective and rapid approach to triage women with mild cervical lesions
por: Magkana, Maria, et al.
Publicado: (2021)

Evaluation of the p16 and Ki-67 Biomarkers as Predictors of the Recurrence of Premalignant Cervical Cancer Lesions after LEEP Conization
por: Leite, Paulo Macêdo de Oliveira, et al.
Publicado: (2017)

An Adsorptive and Antioxidant Vaginal Gel Clears High-Risk HPV- and p16/Ki-67-Associated Abnormal Cytological Cervical Findings: A post-hoc Subgroup Analysis of a Prospective Randomized Controlled Trial on CIN2 and p16 Positive CIN1
por: Major, Attila Louis, et al.
Publicado: (2021)

HPV-Testing in Follow-up of Patients Treated for CIN2+ Lesions
por: Mariani, Luciano, et al.
Publicado: (2016)

Efficacy and safety of an adsorbent and anti-oxidative vaginal gel on CIN1 and 2, on high-risk HPV, and on p16/Ki-67: a randomized controlled trial
por: Major, Attila Louis, et al.
Publicado: (2020)

Clinical validation of p16/Ki‐67 dual‐stained cytology triage of HPV‐positive women: Results from the IMPACT trial
por: Wright, Thomas C., et al.
Publicado: (2021)

Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China
por: Yu, Lu-Lu, et al.
Publicado: (2016)

Liquid-Based Screening Tests Results: HPV, Liquid-Based Cytology, and P16/Ki67 Dual-Staining in Private-Based Opportunistic Cervical Cancer Screening
por: Trzeszcz, Martyna, et al.
Publicado: (2021)

Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years?
por: Trzeszcz, Martyna, et al.
Publicado: (2021)

Utility of P16/INK4a and Ki-67 in Preneoplasticand Neoplastic Lesions of Cervix
por: Sangwaiya, Ashok, et al.
Publicado: (2018)

Assessment of p16 and Ki67 Immunohistochemistry Expression in Squamous Intraepithelial Lesion with Cytohistomorphological Correlation
por: Ghosh, Apurv, et al.
Publicado: (2020)

Detection of cervical precancerous lesions with Aptima HPV assays using SurePath preservative fluid specimens
por: Chernesky, Max, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3d93htgctaknjn4unftp2tpbum